D. Azorsa, I. Gonzales, G. Basu, A. Choudhary, S. Arora et al., Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer, Journal of Translational Medicine, vol.7, issue.1, p.43, 2009.
DOI : 10.1186/1479-5876-7-43

C. Ma and J. Janetka, Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics, Trends in Molecular Medicine, vol.17, issue.2, pp.88-96, 2011.
DOI : 10.1016/j.molmed.2010.10.009

D. Matthews, F. Yakes, J. Chen, M. Tadano, L. Bornheim et al., Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo, Cell Cycle, vol.6, issue.1, pp.104-110, 2007.
DOI : 10.4161/cc.6.1.3699

L. Parsels, M. Morgan, D. Tanska, J. Parsels, B. Palmer et al., Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells, Molecular Cancer Therapeutics, vol.8, issue.1, pp.45-54, 2009.
DOI : 10.1158/1535-7163.MCT-08-0662

M. Morgan, L. Parsels, L. Zhao, J. Parsels, M. Davis et al., Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair, Cancer Research, vol.70, issue.12, pp.4972-4981, 2010.
DOI : 10.1158/0008-5472.CAN-09-3573

L. Kunz-schughart, M. Kreutz, and R. Knuechel, Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology, International Journal of Experimental Pathology, vol.62, issue.42, pp.1-23, 1998.
DOI : 10.1046/j.1365-2613.1998.00051.x

L. Kunz-schughart, Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor, Cell Biology International, vol.23, issue.3, pp.157-161, 1999.
DOI : 10.1006/cbir.1999.0384

L. Kunz-schughart, J. Freyer, F. Hofstaedter, and R. Ebner, The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model, Journal of Biomolecular Screening, vol.7, issue.1, pp.273-285, 2004.
DOI : 10.1006/excr.2001.5467

R. Sutherland, Cell and environment interactions in tumor microregions: the multicell spheroid model, Science, vol.240, issue.4849, pp.177-184, 1988.
DOI : 10.1126/science.2451290

B. Desoize and J. Jardillier, Multicellular resistance: a paradigm for clinical resistance?, Critical Reviews in Oncology/Hematology, vol.36, issue.2-3, pp.193-207, 2000.
DOI : 10.1016/S1040-8428(00)00086-X

H. Mellor, D. Ferguson, and R. Callaghan, A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs, British Journal of Cancer, vol.20, issue.3, pp.302-309, 2005.
DOI : 10.1038/sj.bjc.6602710

W. Fayad, S. Brnjic, D. Berglind, S. Blixt, M. Shoshan et al., Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model, International Journal of Cancer, vol.8, issue.10, pp.2450-2455, 2009.
DOI : 10.1002/ijc.24627

A. Sakaue-sawano, H. Kurokawa, T. Morimura, A. Hanyu, H. Hama et al., Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression, Cell, vol.132, issue.3, pp.487-498, 2008.
DOI : 10.1016/j.cell.2007.12.033

A. Ivascu and M. Kubbies, Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis, Journal of Biomolecular Screening, vol.117, issue.8, pp.922-932, 2006.
DOI : 10.1177/1087057106292763

B. Ewald, D. Sampath, and W. Plunkett, H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation, Molecular Cancer Therapeutics, vol.6, issue.4, pp.1239-1248, 2007.
DOI : 10.1158/1535-7163.MCT-06-0633

M. Morgan, L. Parsels, J. Parsels, A. Mesiwala, J. Maybaum et al., Role of Checkpoint Kinase 1 in Preventing Premature Mitosis in Response to Gemcitabine, Cancer Research, vol.65, issue.15, pp.6835-6842, 2005.
DOI : 10.1158/0008-5472.CAN-04-2246

A. Tse, K. Rendahl, T. Sheikh, H. Cheema, K. Aardalen et al., CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo, Clinical Cancer Research, vol.13, issue.2, pp.591-602, 2007.
DOI : 10.1158/1078-0432.CCR-06-1424

J. Friedrich, C. Seidel, R. Ebner, and L. Kunz-schughart, Spheroid-based drug screen: considerations and practical approach, Nature Protocols, vol.272, issue.3, pp.309-333, 2009.
DOI : 10.1038/nature03664

Y. Matsuda, T. Ishiwata, Y. Kawamoto, K. Kawahara, W. Peng et al., Morphological and cytoskeletal changes of pancreatic cancer cells in three-dimensional spheroidal culture, Medical Molecular Morphology, vol.24, issue.4, pp.211-218, 2010.
DOI : 10.1007/s00795-010-0497-0

S. Dangi-garimella, S. Krantz, M. Barron, M. Shields, M. Heiferman et al., Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2, Cancer Research, vol.71, issue.3, pp.1019-1028, 2011.
DOI : 10.1158/0008-5472.CAN-10-1855

Y. Yamanaka, H. Friess, M. Kobrin, M. Buchler, H. Beger et al., Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness, Anticancer Res, vol.13, pp.565-569, 1993.

S. Ueda, S. Ogata, H. Tsuda, N. Kawarabayashi, M. Kimura et al., The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness, Pancreas, vol.29, issue.1, pp.1-8, 2004.
DOI : 10.1097/00006676-200407000-00061

H. Mizushima, X. Wang, S. Miyamoto, and E. Mekada, Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures, Journal of Cell Science, vol.122, issue.23, pp.4277-4286, 2009.
DOI : 10.1242/jcs.054551

A. Jimeno, A. Tan, J. Coffa, N. Rajeshkumar, P. Kulesza et al., Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer, Cancer Research, vol.68, issue.8, pp.2841-2849, 2008.
DOI : 10.1158/0008-5472.CAN-07-5200

E. Smitskamp-wilms, H. Pinedo, G. Veerman, R. Van-haperen, V. Peters et al., Postconfluent multilayered cell line cultures for selective screening of gemcitabine, European Journal of Cancer, vol.34, issue.6, pp.921-926, 1998.
DOI : 10.1016/S0959-8049(97)10125-3

J. Friedrich, R. Ebner, and L. Kunz-schughart, Experimental anti-tumor therapy in 3-D: Spheroids ??? old hat or new challenge?, International Journal of Radiation Biology, vol.10, issue.11-12, pp.849-871, 2007.
DOI : 10.1007/s10456-004-8911-7

M. Genc, C. Kreder, N. Barten-van-rijbroek, A. Stalpers, L. Haveman et al., Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids, Journal of Cancer Research and Clinical Oncology, vol.130, issue.1, pp.45-51, 2004.
DOI : 10.1007/s00432-003-0506-y

V. Lobjois, C. Frongia, S. Jozan, I. Truchet, and A. Valette, Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids, European Journal of Cancer, vol.45, issue.13, pp.2402-2411, 2009.
DOI : 10.1016/j.ejca.2009.05.026

L. Huxham, A. Kyle, J. Baker, L. Nykilchuk, and A. Minchinton, Microregional Effects of Gemcitabine in HCT-116 Xenografts, Cancer Research, vol.64, issue.18, pp.6537-6541, 2004.
DOI : 10.1158/0008-5472.CAN-04-0986

D. Tuveson, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, vol.324, pp.1457-1461, 2009.

I. Tannock, C. Lee, J. Tunggal, D. Cowan, and M. Egorin, Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy, Clin Cancer Res, vol.8, pp.878-884, 2002.

P. Olive, J. Banath, and L. Sinnott, Phosphorylated Histone H2AX in Spheroids, Tumors, and Tissues of Mice Exposed to Etoposide and 3-Amino-1,2,4-Benzotriazine-1,3-Dioxide, Cancer Research, vol.64, issue.15, pp.5363-5369, 2004.
DOI : 10.1158/0008-5472.CAN-04-0729

S. Cho, C. Toouli, G. Fujii, C. Crain, and D. Parry, Chk1 is Essential for Tumor Cell Viability Following Activation of the Replication Checkpoint, Cell Cycle, vol.4, issue.1, pp.131-139, 2005.
DOI : 10.4161/cc.4.1.1299

M. Morgan, L. Parsels, J. Parsels, T. Lawrence, and J. Maybaum, The Relationship of Premature Mitosis to Cytotoxicity in Response to Checkpoint Abrogation and Antimetabolite Treatment, Cell Cycle, vol.5, issue.17, pp.1983-1988, 2006.
DOI : 10.4161/cc.5.17.3184

F. Hirschhaeuser, H. Menne, C. Dittfeld, J. West, W. Mueller-klieser et al., Multicellular tumor spheroids: An underestimated tool is catching up again, Journal of Biotechnology, vol.148, issue.1, pp.3-15, 2010.
DOI : 10.1016/j.jbiotec.2010.01.012